TipRanks
GlaxoSmithKline (MX:GSKN)
:GSKN
Mexico Market
GSKN
GlaxoSmithKline
RESEARCH TOOLSreports

GlaxoSmithKline (GSKN) Ratios

0 Followers

GlaxoSmithKline Ratios

MX:GSKN's free cash flow for Q2 2026 was £0.73. For the 2026 fiscal year, MX:GSKN's free cash flow was decreased by £ and operating cash flow was £0.06. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 0.82 0.82 0.78 0.88 0.91
Quick Ratio
 0.52 0.54 0.52 0.62 0.68
Cash Ratio
 0.14 0.16 0.17 0.14 0.16
Solvency Ratio
 0.16 0.18 0.11 0.12 0.34
Operating Cash Flow Ratio
 0.37 0.33 0.30 0.29 0.36
Short-Term Operating Cash Flow Coverage
 1.86 2.38 3.01 2.20 2.16
Net Current Asset Value
£ -27.00B£ -27.54B£ -29.38B£ -35.14B£ -29.28B
Leverage Ratios
Debt-to-Assets Ratio
 0.30 0.29 0.29 0.31 0.35
Debt-to-Equity Ratio
 1.03 1.08 1.24 1.35 1.98
Debt-to-Capital Ratio
 0.51 0.52 0.55 0.57 0.66
Long-Term Debt-to-Capital Ratio
 0.44 0.47 0.50 0.51 0.60
Financial Leverage Ratio
 3.50 3.73 4.35 4.42 5.68
Debt Service Coverage Ratio
 2.06 2.52 2.16 1.91 1.70
Interest Coverage Ratio
 11.37 12.14 6.11 8.70 7.52
Debt to Market Cap
 0.25 0.24 0.29 0.37 0.34
Interest Debt Per Share
 9.44 9.07 8.66 11.72 10.85
Net Debt to EBITDA
 1.38 1.37 1.99 2.12 2.01
Profitability Margins
Gross Profit Margin
73.29%72.40%71.16%71.76%67.42%
EBIT Margin
25.52%24.76%13.12%22.39%22.01%
EBITDA Margin
32.99%31.84%21.25%29.95%29.33%
Operating Profit Margin
24.12%25.52%12.82%22.24%21.94%
Pretax Profit Margin
17.78%22.66%11.08%19.99%19.19%
Net Profit Margin
14.52%17.50%8.21%16.25%51.00%
Continuous Operations Profit Margin
15.85%19.25%9.41%17.50%16.78%
Net Income Per EBT
81.66%77.23%74.06%81.27%265.74%
EBT Per EBIT
73.74%88.76%86.47%89.90%87.49%
Return on Assets (ROA)
7.81%9.37%4.33%6.55%24.87%
Return on Equity (ROE)
28.35%34.96%18.84%28.96%141.12%
Return on Capital Employed (ROCE)
19.92%21.03%10.65%13.95%17.23%
Return on Invested Capital (ROIC)
16.04%16.61%8.51%11.37%13.62%
Return on Tangible Assets
12.84%15.33%6.97%10.33%38.56%
Earnings Yield
6.48%7.75%4.67%8.35%25.58%
Efficiency Ratios
Receivables Turnover
 4.11 4.22 5.23 3.21 4.72
Payables Turnover
 0.62 0.59 2.61 1.81 2.47
Inventory Turnover
 1.41 1.52 1.60 1.22 1.86
Fixed Asset Turnover
 3.31 3.26 3.11 2.39 3.05
Asset Turnover
 0.54 0.54 0.53 0.40 0.49
Working Capital Turnover Ratio
 -7.68 -7.62 -8.06 -11.82 -6.66
Cash Conversion Cycle
 -242.91 -295.60 158.82 210.33 126.30
Days of Sales Outstanding
 88.76 86.54 69.79 113.58 77.40
Days of Inventory Outstanding
 258.50 239.38 228.69 298.68 196.60
Days of Payables Outstanding
 590.17 621.51 139.66 201.93 147.70
Operating Cycle
 347.26 325.92 298.48 412.26 273.99
Cash Flow Ratios
Operating Cash Flow Per Share
 3.98 3.53 3.22 3.89 4.05
Free Cash Flow Per Share
 2.87 2.88 1.75 3.09 3.35
CapEx Per Share
 1.11 0.65 1.46 0.81 0.70
Free Cash Flow to Operating Cash Flow
 0.72 0.82 0.55 0.79 0.83
Dividend Paid and CapEx Coverage Ratio
 1.63 1.87 1.21 1.78 1.44
Capital Expenditure Coverage Ratio
 3.59 5.42 2.20 4.83 5.80
Operating Cash Flow Coverage Ratio
 0.44 0.40 0.39 0.34 0.39
Operating Cash Flow to Sales Ratio
 0.24 0.22 0.21 0.26 0.28
Free Cash Flow Yield
7.75%7.90%6.48%10.60%11.55%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 15.45 12.91 21.45 11.98 3.91
Price-to-Sales (P/S) Ratio
 2.24 2.26 1.76 1.95 1.99
Price-to-Book (P/B) Ratio
 4.22 4.51 4.03 3.47 5.52
Price-to-Free Cash Flow (P/FCF) Ratio
 12.91 12.66 15.42 9.43 8.66
Price-to-Operating Cash Flow Ratio
 9.33 10.32 8.41 7.48 7.17
Price-to-Earnings Growth (PEG) Ratio
 0.36 0.10 -0.44 0.00 -0.36
Price-to-Fair Value
 4.22 4.51 4.03 3.47 5.52
Enterprise Value Multiple
 8.16 8.46 10.26 8.62 8.81
Enterprise Value
 89.42B 88.02B 68.38B 78.26B 75.74B
EV to EBITDA
 8.16 8.46 10.26 8.62 8.81
EV to Sales
 2.69 2.69 2.18 2.58 2.58
EV to Free Cash Flow
 15.54 15.11 19.14 12.51 11.22
EV to Operating Cash Flow
 11.21 12.32 10.43 9.92 9.28
Tangible Book Value Per Share
 -3.49 -3.82 -4.62 -5.53 -5.60
Shareholders’ Equity Per Share
 8.79 8.07 6.71 8.40 5.26
Tax and Other Ratios
Effective Tax Rate
 0.11 0.15 0.15 0.12 0.13
Revenue Per Share
 16.54 16.13 15.39 14.97 14.57
Net Income Per Share
 2.40 2.82 1.26 2.43 7.43
Tax Burden
 0.82 0.77 0.74 0.81 2.66
Interest Burden
 0.70 0.92 0.84 0.89 0.87
Research & Development to Revenue
 0.22 0.23 0.20 0.21 0.19
SG&A to Revenue
 0.28 0.28 0.35 0.31 0.29
Stock-Based Compensation to Revenue
 0.00 0.00 0.01 0.00 0.00
Income Quality
 1.58 1.28 2.22 1.29 1.49
Currency in GBP